什么是慢性阻塞性肺病（COPD）？
慢性阻塞性肺病（COPD）是一个概括的名称，该名称含概两种主要的失调 － 气肿及慢性支气管炎 －这两种疾病的特征是空气无法顺畅地流入及流出肺部。气肿及慢性支气管炎通常是共存的。因此医生一般会统称这两种疾病为慢性阻塞性肺病（COPD）。 COPD是一种渐进恶化的气道疾病，特征是病人的肺部会渐渐失去功能。——慢性阻塞性肺病协会（新加坡）
香港胸肺基金会：慢性阻塞性肺病
COPD是一种慢性进行性加重的气道疾病，其特征为气流受限，并有慢性支气管炎和肺气肿。患者小气道狭窄(图1)，很难吸入和排出肺内的空气。COPD患者的第一秒用力呼气量(forced expiratory volume in 1 second, FEV 1，测量肺功能的指标)比正常不吸烟者低三至四倍(图2)。由于COPD的症状并不特异，多数患者在病程晚期才就诊。
海南医学院：慢性阻塞性肺病
是一组以肺实质与小气道受到病理损害后,导致慢性不可逆性气道阻塞、呼气阻力增加、肺功能不全为共同特征的肺疾病的统就。主指慢支、肺气肿、支气管哮喘、支扩。
朱琇吟藥師：COPD的臨床處理及治療
慢性阻塞性肺部疾病(Chronic Obstructive Pulmonary Disease, COPD)為一慢性呼吸道疾病，包括咳嗽、痰液的產生、呼吸困難、氣體交換困難、呼吸量受到限制。
蕭光明：慢性阻塞性肺疾病與睡眠
它的COPD新定義，是以肺功能呈現不可完全逆轉的阻塞性通氣障礙為定義，診斷基準為病人吸過支氣管擴張劑之後，若FEV1/FVC比值仍低於70%，即可稱之為COPD，而嚴重度評估則是以FEV1佔正常值的百分率為評估指標。
钮善福：面罩机械通气氧疗治疗呼吸衰竭的进展（DOC）
机械通气应用于临床近70年的历史。十多年来，由于高科技（如精密微传感器压力、流量、容积和气体分析等）和电脑微处理技术应用于呼吸衰竭（呼衰）的病理生理、呼吸机及其机械通气各种生理效应的研究，从而使呼吸监护和呼吸机的性能不断优化。
杨文兰、邓星奇、蔡映云：慢性阻塞性肺病长期家庭氧疗的研究进展
长期家庭氧疗是慢性阻塞性肺病缓解期患者康复治疗的重要措施，可改善患者生命质量，延长生存时间。
COPD药物治疗进展
与支气管哮喘药物治疗的显著疗效相比，ＣＯＰＤ药物治疗的效果要差得多，唯一可以延缓ＣＯＰＤ进展的方法就是戒烟。张荣葆摘译自第９届亚太呼吸年会论文汇编
ＣＯＰＤ诊断和治疗２００４新指南
ＣＯＰＤ是一种可以预防、可以治疗的疾病，以不完全可逆的气流受限为特点。由于有害颗粒或气体（主要是吸烟）的影响，肺部产生异常的炎症反应，从而产生气流受限，常呈进行性加重。ＣＯＰＤ不仅影响肺，也可以引起显著的全身反应。
《默克诊疗手册》慢性阻塞性肺病
在美国,1994年估计有1600万COPD病人,比1982年多60%.1993年,COPD是第4大致死原因,达95910人---超过1979年的两倍.从1979-1993年,年龄-校准的COPD死亡率增加了几乎50%(从14%~20%),
世界慢阻肺日专题
2004年11月17日是第三个世界慢性阻塞性肺疾病日，为“慢性阻塞性肺疾病——不容忽视的病害”。
慢性阻塞性肺疾病(COPD)病友會
慢阻肺病資訊網

呼吸医学网站介绍

Pocket Guide to COPD Diagnosis, Management, and Prevention(PDF)
Chronic Obstructive Pulmonary Disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases.
GOLD Patient Guide: What You and Your Family Can Do About COPD(PDF)
Doctors cannot cure COPD, but they can help to improve your symptoms and slow the damage to your lungs.
GOLD Teaching slide set(PPT)
GOLD Teaching slide set(HTML)
In 2000, the WHO estimated 2.74 million deaths worldwide from COPD.
Measuring Symptom Response to Pharmacological Interventions in Patients with COPD: A Review of Instruments Used in Clinical Trials
Chronic obstructive pulmonary disease (COPD) imposes a substantial burden on patients, their families, healthcare systems and society in general. In the US, the total direct costs of COPD were estimated at $15.5 billion in 1993.
Is a Long-Acting Inhaled Bronchodilator the First Agent to Use in Stable Chronic Obstructive Pulmonary Disease?
Current evidence supports the recommendation of the Global Initiative for Chronic Obstructive Lung Disease guidelines of at least one of the two classes of long-acting inhaled bronchodilators as initial maintenance therapy for symptomatic COPD.
Update on the ATS Guidelines for COPD
In 1995, the American Thoracic Society (ATS) published a position paper titled, "Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD)."
Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
When selecting an aerosol delivery device for patients with asthma and COPD, the following should be considered: device/drug availability; clinical setting; patient age and the ability to use the selected device correctly; device use with multiple medications; cost and reimbursement; drug administration time; convenience in both outpatient and inpatient settings; and physician and patient preference.
Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study
Early pulmonary rehabilitation after admission to hospital for acute exacerbations of COPD is safe and leads to statistically and clinically significant improvements in exercise capacity and health status at three months.
COPD (Chronic Obstructive Pulmonary Disease) (Patient Education Institute) - Requires Flash Player
Chronic Obstructive Pulmonary Disease (National Heart, Lung, and Blood Institute)(PDF)
The symptoms of COPD can range from chronic cough and sputum production to severe disabling shortness of breath. In some individuals, chronic cough and sputum production are the first signs that they are at risk for developing the airflow obstruction and shortness of breath characteristic of COPD.
Facts about Chronic Obstructive Pulmonary Disease (COPD) (National Center for Environmental Health)
Cigarette smoking is the most common cause of COPD. Most people with COPD are smokers or former smokers.
JAMA Patient Page: Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a term used to describe two related lung diseases: chronic bronchitis and emphysema.
Arterial Blood Gases, ABGs
Blood gas measurements are used mainly to evaluate the severity of an O2/CO2 or pH imbalance.
Spirometry
The spirometer measures two important numbers; FEV1 and forced vital capacity FEV6 (FVC).
CURRENT TREATMENT FOR EMPHYSEMA/COPD
Recently, researchers at the Emphysema/ COPD Center at National Jewish have been studying the outcome of new procedures to treat this condition.
Nutritional Guidelines for People With COPD
Changing your eating habits will not cure COPD, but it can help you feel better.
How to plan for air travel when you need supplemental oxygen
Some people with lung or heart disease, such as those with congestive heart failure, cardiomyopathy or chronic obstructive pulmonary disease (emphysema), may need supplemental oxygen, especially during air travel — even if they don't require it on the ground.
Living with Advanced Lung Disease: A Guide for Family Caregivers(PDF)
Advanced lung disease, like so many chronic illnesses, afflicts one individual, but affects entire families.
ERS-COPD Guidelines